Hosted on MSN7mon
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma GiantVLS-01, an oral formulation of N,N-dimethyltryptamine (DMT), is designed to be administered ... Cover image made with AI ...
Researchers at the AI security company Adversa AI have found ... dispose of bodies, extract DMT, and, of course, build a bomb," according to Adversa CEO and cofounder Alex Polyakov.
Small Pharma is the first company to conduct clinical trials to treat depression with the psychedelic N,N-dimethyltryptamine (DMT). “Combining pharmacological and psychological intervention is a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback